SIOG COVID-19 Working Group recommendations on COVID-19 therapeutic approaches in older adults with cancer
- PMID: 37393123
- PMCID: PMC10288307
- DOI: 10.1016/j.jgo.2023.101564
SIOG COVID-19 Working Group recommendations on COVID-19 therapeutic approaches in older adults with cancer
Keywords: COVID-19; Cancer; Mortality; Older patients; SARS-CoV-2; Therapeutics.
Conflict of interest statement
Declaration of Competing Interest Dr. Battisti reports receiving travel grants from Exact Sciences, Pfizer, and Lilly; speaker fees from AbbVie, Roche, Sanofi, and Novartis; and serving on advisory boards of Pfizer, Abbott, and Sanofi. Dr. Loh reports receiving honoraria from Pfizer and acting as a consultant to Seattle Genetics. Dr. Kanesvaran reports receiving honoraria for advisory boards and speaking engagements from BMS, MSD, Astellas, J&J, Eisai, Ipsen, Pfizer, Merk, AstraZaneca, Novartis.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous